with

Riyadh International Philosophy Conference 2024 Concludes with a Focus on Quality of Life

Day 3 explored the philosophical contributions to the quality of life, and the ethical implications of AI and its impact…

3 days ago

Microland Foundation and KMF celebrate wellness in the community by distributing dignity kits to patients with disease-related suffering on the occasion of World Disability Day

BENGALURU, India, Dec. 6, 2024 /PRNewswire/ -- In a significant step towards ensuring care for patients with disease-related suffering, Microland Foundation,…

3 days ago

Deepak Nitrite Chairman & Managing Director, Shri Deepak C Mehta, Honored with ICC Lifetime Achievement Award for 2023

•  Recognized for Outstanding Contribution to Chemical Manufacturing at the 59th ICC Annual Awards in Mumbai VADODARA, India, Sept. 26,…

3 days ago

AMD Redefines Business Productivity with Third-Gen Ryzen AI PRO Processors: Powering the Future of Advanced AI Computing

MUMBAI, India, Dec. 9, 2024 /PRNewswire/ -- AMD (NASDAQ: AMD) has launched its third-generation commercial AI mobile processors, the Ryzen™…

3 days ago

WSPN Partners with Fractal to Expand Stablecoin Access on Bitcoin

SINGAPORE, Dec. 9, 2024 /PRNewswire/ -- WSPN (Worldwide Stablecoin Payment Network), a global digital payments company, today announced a strategic…

3 days ago

Automechanika Dubai supports the UAEs eMobility goals with a platform for innovation and collaboration

The Innovation4Mobility Conference at Automechanika Dubai will highlight the technologies, policies, and partnerships that are accelerating the adoption of electric…

4 days ago

Embitel continues its journey with the Volkswagen Group, advancing toward a brighter digital future

BENGALURU, India, Dec. 7, 2024 /PRNewswire/ -- Embitel Technologies, a globally recognized provider of cutting-edge product engineering services and end-to-end digital…

4 days ago

Moove Partners with Waymo to Redefine the Future of Urban Mobility

DUBAI, UAE, Dec. 5, 2024 /PRNewswire/ -- Moove, a global leader in innovative mobility solutions, is proud to announce a groundbreaking…

4 days ago

TECVAYLI (teclistamab) demonstrates potential as frontline combination therapy for patients with newly diagnosed multiple myeloma

100 percent of evaluable patients for minimal residual disease (MRD) testing achieved MRD negativity in MajesTEC-5 as induction therapy and MajesTEC-4…

4 days ago

Longer-term data for Novartis Scemblix reinforce superior efficacy with favorable safety and tolerability profile in adults with newly diagnosed CML

Scemblix demonstrated sustained superior major molecular response (MMR) vs. all investigator-selected TKIs (74.1% vs. 52%) and vs. imatinib alone (76.2%…

4 days ago